DOCSLIB.ORG

Review Welsh

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Review Welsh INNOVATION TECHNOLOGY HEALTHCARE PHARMACY Welsh Review SUMMER SPECIAL THE SEASON'S MAJOR HEALTH HAZARDS BIOSIMILAR MEDICINES WHAT YOU NEED TO KNOW WELSH PHARMACY AWARDS THE 2017 SHORTLIST IS REVEALED MEET AND GREET HOW ONE LADY OVERHAULED THE PATIENT EXPERIENCE THE WORD ON THE STREET ISSUE HOMELESSNESS AND PHARMACISTS 33 - 2017 VISIT US AT WWW.WALESHEALTHCARE.COM 5688 QIPP advertorial in Northern Ireland Healthcare Review (NIH) v1.qxp_QIPP Zeroderma advertorial 18/01/2017 13:43 Page 1 wIdER CHoICE, GREATER SAvINGS FRom THE ZERodERmA RANGE WWW.WALESHEALTHCARE.COM WPR WELCOME ISSUE 33 - 2017 MEDCOM www.waleshealthcare.com www.pharmacy-life.co.uk Sarah Nelson Editor EDITOR [email protected] SARAH NELSON [email protected] NATIONAL ACCOUNTS MANAGER CHRIS FLANNAGAN [email protected] NATIONAL ACCOUNTS MANAGER (SPECIAL FEATURES) HANNA DEVON [email protected] EDITOR'S LETTER How much could you save ACCOUNTS MANAGER DONNA MARTIN [email protected] Welcome to the latest edition of Welsh Pharmacy EVENTS MANAGER Review! on emollient prescribing? BRIDGET MCCABE [email protected] The Zeroderma emollient range offers MARKETING MANAGER A long-running joke among my friends services to offer them their own network Survey shows benefits of KELLY ROCK and family is how I must be ‘one of the of support. The health of the homeless a choice of four creams, one ointment, [email protected] ® 19% Zerodouble Emollient Gel cost saving unluckiest people ever’ – and, to be fair, is becoming increasingly magnified, one gel and two bath additives - per pack STUDIO MANAGER Results from a recent survey with over 300 members of DECLAN NUGENT I’ve gifted them a lot of ammunition to and this edition, we weigh up how you providing complete emollient therapy [email protected] ® make this claim. can help – via regular engagement and for moisturising, washing and bathing. the Psoriasis Association using Zerodouble emollient Gel showed that 97% liked the feel of Zerodouble Gel, 91% MANAGING DIRECTOR From my trains breaking down mid- medication delivery methods – and chat ADRIAN MAGINNIS All Zeroderma products are gentle on said it was as good as or better than their current emollient [email protected] journey, phones giving up on me mid- to those pharmacists who are already out the skin and do not contain the harmful and 84% wanted to continue using Zerodouble Gel. IF YOU WISH TO CONTACT US BY text, and restaurants running out of my there, playing their part (beginning on irritant sodium lauryl sulfate (SlS). TELEPHONE - 02890 999 441 preferred dishes mid-order, I’ve come to page 10). Zeroderm® ointment – convenient 37% almost expect these occurrences now. Elsewhere, check out this year’s Zeroderma products are similar in formulation cost saving Whilst every care has been taken in compiling this magazine to ensure that it is correct at In a way, it’s been character-building; summer special (beginning on page 26) to around 50% of emollients currently 3-in-1 emollient therapy per pack the time of going to press, the publishers assume no responsibility for any effects I now know to always plan ahead, expect – covering inhaler technique findings, prescribed by CCGs and offer cost savings SLS-free Zeroderm® Ointment provides a rich from errors or omissions. The opinions of contributors are not necessarily those of the the worst, and stock my handbag with an need-to-know allergy updates, and more 3-in-1 emollient for the management of eczema publisher. No part of this publication may be of up to 37%, with no compromise on reproduced, stored in a retrieval system, or and dry skin conditions. Zeroderm Ointment can transmitted in any form, or by any means, impressive array of essential items, that – and our tremendously talented 2017 patient care. Around 75% of formularies and mechanical, electronic, photocopying, recording be used as a skin cleanser, a bath additive and as a leave-on moisturiser. or otherwise without the prior permission of even Bear Grylls has sought me out for Welsh Pharmacy Awards finalists are prescribing guidelines already include at Medical Communications 2015 Ltd. All rights reserved. Data Protection - Please note, your advice. revealed (beginning on page 15). least one Zeroderma product. The ® mailing details and copies of any articles Having thought about it, though, That’s not all – we once again check ZeroAQS Cream – An SlS-free 24% supplied will be held on a database and may be Zeroderma emollient range is available on cost saving shared with associated companies. Sometimes ‘unlucky’ is a term we’ve been using in with the All Wales Medicines Strategy alternative to Aqueous Cream per pack your details may be obtained from, or made prescription and listed on NHS contract. available to, external companies for marketing far, far too loosely, and is in no way Group (page 46), and delve into the latest ZeroAQS® emollient cream is a cost effective purposes. If you do not wish your details to be used for this purpose, please write to: Database accurate. I’m in fact incredibly lucky – in nutrition (beginning on page 38). A CCG who recently started using the 2-in-1 moisturiser and soap substitute which does Manager, Medical Communications 2015 Ltd, 142-148 Albertbridge Road, Belfast, BT5 4GS. particularly due to the support network Zeroderma range commented: not contain sodium lauryl sulfate (SLS), fragrance Subscription: £120 a year or colour. The Medicines and Healthcare products Regulatory Agency (MHRA) I have around me which is sturdier than Happy reading! ‘Emollient prescribing has been a has directed that SLS-containing Aqueous Cream should carry a safety warning David and Victoria Beckham’s wardrobes useful area to address as part of stating that: ‘aqueous cream may cause skin irritation due to its sodium lauryl combined. Having them by my side sulfate (SLS) content,’ if used as a leave-on emollient. grants me the confidence to try new QIPP. The focus has been on optimising INNOVATION TECHNOLOGY HEALTHCARE PHARMACY things, grateful of the knowledge that patient care by offering emollient Welsh they’re always willing to help me pick up products that patients are happy to use. QIPP By changing from proprietary emollient brands the pieces (literally, as well as figuratively to the cost-effective Zeroderma emollient range, CREATED FOR PHARMACISTS Feedback from GPs has been positive Review CRAFTED BY YOU – I tend to drop things a lot). 1 and changes have been simple to ToolkIT the NHS could save over £13 million p.a. In Conversation with For those less lucky, and lacking a Health Secretary similar unit, members of the sector have implement. Patient care has not been A QIPP & emollients toolkit developed by Medicines Management Vaughan Gething compromised and changes to the teams contains everything needed to implement product changes been admirably branching out their product prescribed have been at practice level. To estimate your potential local savings and find out 6 CHAMPION CYCLIST ALEX DOWSETT THE SPOTLIGHT ON HAEMOPHILIA 1 acceptable to most patients.’ more please visit: www.qipp.trderma.co.uk 0 2 A MIRACLE DRUG? THE LATEST ON ME-CFS h c r a 2017 WELSH PHARMACY AWARDS Thornton & Ross, Linthwaite, GET YOUR APPLICATIONS IN NOW M ISSUE ISSUE , Huddersfield HD7 5QH a FIGHT THE FAKES 114 32 t @MEDCOMwales Medical Communications Ltd THE BATTLE AGAINST COUNTERFEIT MEDICINES - 2017 - 2017 se a ROLLS ON 01484 842217 For FREE samples for patient evaluation plea d VISIT US AT WWW.WALESHEALTHCARE.COM A www.trderma.co.uk C P email: [email protected] [email protected] . 1 WPR | May 2017 | 1 WWW.WALESHEALTHCARE.COM CONTENTS ISSUE 33 - 2017 7 NEW TO THE GAME What opportunities and challenges are biosimilar medicines bringing to the market? 9 SPECIAL COMMUNITY PHARMACY EVENT ANNOUNCED Key figureheads are coming together to discuss new challenges » p.26 10 WORD ON THE STREET How the sector is helping to reshape the health of the homeless 12 ADHD: THE PHARMACIST’S CHALLENGE A new perspective is lessening misdiagnoses of the condition 15 WELSH PHARMACY AWARDS » p.44 » p.15 Meet the 2017 finalists We make happy pharmacists 26 UNDER THE SUN The latest on the season’s health hazards – from That’s because more pharmacies than ever before in Wales are increasing allergies to inhaler technique findings their profits as members of the Cambrian Alliance Group. 36 WELCOME ABOARD Why join them? Community Pharmacy Wales has revealed its new Chairman We’re independent & impartial meaning we’re truly focused on your needs. 40 COELIAC DISEASE » p.7 With over 1,200 members and an annual spending power of £0.5 billion The evolving role of the pharmacist in signposting we save you money on generics, PIs, OTCs & dressings. symptoms And we give you with the professional services & technology you need 44 WHAT’S IN A NAME? to grow your business including e-CASS - our price comparison, stock The social media campaign that’s personalising the face ordering tool that makes you money and saves you time. of healthcare 46 THE JURY IS OUT Contact us today and start making more money. The All Wales Medicines Strategy group on the e: [email protected] prevalence of antimicrobial resistance t: 0845 130 1187 » p.46 w:2 | cambrianalliance.co.uk NIHR | April 2017 WPR | April 2017 | 3 Medcom Scot mag advert.indd 1 3/7/2017 2:25:24 PM WWW.WALESHEALTHCARE.COM WWW.WALESHEALTHCARE.COM NEWS NEWS NEW STUDY been set aside for the protection The app, developed with Welsh of plants and wildlife, wildflower government funding, is targeted at SLEEPING PILLS TO IMPROVE meadows and a bee sanctuary. reducing pressure ulcers developing LINKED TO HIP DIABETES SELF- Sophie Howe, Future in the first place; but when they do Generations Commissioner, occur, it will help make the best use FRACTURES IN MANAGEMENT explained, ‘Projects like this are so of resources by allowing specialist important because as part of the staff to prioritise the most serious A small pilot study has found ELDERLY Future Generations Act it requires cases.
Load more

Recommended publications
  • Annual Report 2013
    Annual Report 2013 “ Being active and having a positive outlook on life is what keeps me going every day.” Overview of 2013 “ Our performance in 2013 was defined by remarkable &R D output and further delivery of sustained financial performance for our shareholders.” Please go to page 4 for more More at gsk.com Performance highlights £26.5bn £8.0bn £7.0bn £5.2bn Group turnover Core* operating profit Total operating profit Returned to shareholders 6 112.2p 112.5p 13% Major medicines approved Core* earnings per share Total earnings per share Estimated return on R&D investment 10 6 1st 1st Potential phase III study starts in 2014/15 Potential medicines with phase III data in Access to Medicines Index Pharmaceutical company to sign AllTrials expected 2014/15 campaign for research transparency Front cover story Betty, aged 65, (pictured) has Chronic “ Health is important to me, Obstructive Pulmonary Disease (COPD). She only has 25% lung capacity. This means I try to take care of my she finds even everyday tasks difficult, but medicines and inhaled oxygen allow her to health with all the tools live as normal a life as she can. Betty’s mindset I have and do the best is to stay busy and active, so every week she goes to rehab exercise classes. that I can with it.” COPD is a disease of the lungs that leads to Betty, COPD patient, damaged airways, causing them to become North Carolina, USA narrower and making it harder for air to get in and out. 210 million people around the world are estimated to have COPD.
    [Show full text]
  • In This Section
    Strategic report In this section Chairman’s statement 2 CEO’s review 4 Business overview 6 The global context 8 Our business model 12 Our strategic priorities 14 How we performed 16 Risk management 18 Grow 20 Deliver 32 Simplify 44 Our financial architecture 48 Responsible business 50 Financial review 58 Strategic report Chairman’s statement Chairman’s statement To shareholders The value of the significant changes that have been made in recent years is evidenced in our performance this year “ Since Sir Andrew became It is clear from the following pages that Through the Audit & Risk Committee, we the Group made good progress against oversee the issues and challenges faced by CEO, the company has its strategy in 2013. management, and encourage the creation of an environment in which GSK can achieve The Board believes the business is seeing returned £30 billion its strategic ambitions in a responsible and the benefits of the significant changes the sustainable manner. to shareholders.” management team has driven over recent years to deliver sustainable growth, reduce risk and I have no doubt that commercial success is enhance returns to shareholders. directly linked to operating in a responsible way and which meets the changing expectations of The notably strong performance from the society. In this respect, the company continues R&D organisation in 2013 – with six major to adopt industry-leading positions on a range new product approvals in areas including of issues. respiratory disease, HIV and cancer – is critical to the longer-term prospects of the The announcement of plans during 2013 to Group.
    [Show full text]
  • © 2008 Canadian Medical Association Or Its Licensors
    Early release, published at www.cmaj.ca on April 2, 2012. Subject to revision. March 28, 2012 After not eating for up to 11 days and working out four hours daily, Damian Mangat, then 16 years old, was still dissatisfied with her weight when she came across a novel proposition. While part of an outpatient program at a hospital in Toronto, she met a slender girl who disclosed her technique for keeping thin: drink alcohol while consuming no food. Mangat decided to give it a try. “I thought ‘perfect, I already love to drink when I can get it, and now I won’t have to worry about the dizziness because now when I need energy I can just take a shot of something,” she says. “It seemed to work. It seemed to be the magic answer for me.” Such a coupling of an eating disorder with alcohol abuse has been coined “drunkorexia.” Mangat, now 40 and a mature student at a university in Toronto, says the practice is common among college-age women and she often hears talk of foregoing food to save calories for alcohol. “The thinking is first of all, I’ll save the calories,” she says. “Secondly, I’ll get drunk on less and I’ll look good in what I’m wearing, and then later if I do end up eating, I can always throw it up because the booze makes it easy to throw it up.” Drunkorexia is not recognized in any clinical inventory but shares pop- psychology status with a number of other troublesome behaviours such as orthorexia (an extreme preoccupation with eating foods perceived to be healthy and avoiding foods that are not), manorexia (the male version of anorexia nervosa) and bridorexia (when a bride- to-be fasts to ensure she can fit into a certain size dress).
    [Show full text]
  • Alcohol Responsibly and Ending Tobacco Use, Plus Caffeine - Dr
    MHE-110 – Chapter Nine – Drinking Alcohol Responsibly and Ending Tobacco Use, plus Caffeine - Dr. Dave Shrock Chapter Nine Alcohol - an overview Alcohol and ending Tobacco Use 13th pp. 239-240; 12th pp. 232-223 • alcohol is the most widely used drug in the United (including caffeine) States • 86% of Americans consume alcohol 13th edition, pp. • 10% are heavy drinkers…who consume half of all the 241-269 alcohol produced 12th edition: • no other form of addiction or disability costs the US pp. 231-261 more than alcohol use/abuse annually Excessive alcohol use causes 88,000 deaths annually (chapter eight) twice as many as illicit drugs • lost work time, illness, insurance, accidents, medical costs take a toll on all of us…25% of all medical costs in the US are alcohol related Alcohol: The world’s most what is alcohol? dangerous drug? 13th, pp. 239-240; 12th pp. 232-233 The Lancet Medical Journal - 1 November, 2016 • alcohol is a byproduct of fermentation • In a recent article published in of vegetable or fruit pulp or ‘mash’ the British medical journal The this produces a concentration of Lancet, when considering the alcohol up to 14% drug’s damage to: • distillation is a further process by •one’s self capturing the vapors from heating • one’s family the mash, and mix this with water • the environment • proof is the measure of % of alcohol, which means the % • economic cost of alcohol is half of the ‘proof rating’ • Alcohol is the world’s most • some alcohol is 152 proof, or 71% alcohol most beers are damaging drug to individuals 8 proof, or 4% alcohol.
    [Show full text]
  • GCE a Level 1083/01 BUSINESS STUDIES –
    GCE A level 1083/01 S15-1083-01 BUSINESS STUDIES – BS3 A.M. WEDNESDAY, 10 June 2015 2 hours 1083 010001 ADDITIONAL MATERIALS In addition to this examination paper, you will need: • a calculator; • a 12 page answer book. INSTRUCTIONS TO CANDIDATES Use black ink or black ball-point pen. Answer all the questions. Write your answers in the separate answer book provided. INFORMATION FOR CANDIDATES The number of marks is given in brackets at the end of each question. You are reminded that assessment will take into account the quality of written communication used in answers that involve extended writing in questions 4 and 5. You are reminded that questions 4 and 5 are synoptic and so will test understanding of the connections between different elements of the subject. © WJEC CBAC Ltd. AM*(S15-1083-01) 2 Study the information provided about GlaxoSmithKline plc and answer the questions that follow. BACKGROUND GlaxoSmithKline plc (GSK) is a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. It has three primary areas of business: pharmaceuticals, vaccines and consumer healthcare. Its consumer products include 5 Ribena, Macleans toothpaste, Panadol headache pills, Lucozade and Horlicks. The company can trace its history back to 1715 when Sylvanus Bevan established his pharmacy in Plough Court in London. In 1880, his descendants founded Burroughs Wellcome and Company which, eventually in 1995, merged with the Australian company Glaxo to form Glaxo Wellcome. The American branch of the business can trace its history back to 1830 when John K Smith 10 opened his first drugstore.
    [Show full text]
  • Pharmaceutical Giant Consolidates Worldwide Facilities Management Services
    CASE STUDY From 300 to 3: Pharmaceutical Giant Consolidates Worldwide Facilities Management Services Client: GlaxoSmithKline The Opportunity Matter: Outsourcing contract strategy, UK-headquartered GlaxoSmithKline (GSK) is a FTSE structuring and negotiation 100-listed research-based pharmaceutical company that employs 99,000 people in more than 100 countries. GSK Area of Law: Outsourcing has a seven percent share of the world medicine/medical Result: Significantly increased profits and efficiency product market and, through its consumer health division, for GSK by replacing more than 300 sells products under household-name brands like alli, worldwide service providers using unique Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne contracts with a select number of global and Panadol. providers using standardised agreements. GSK has grown both organically and through acquisition, contracting service suppliers one at a time as the need arose. By the time it enlisted Pillsbury’s help, GSK’s facilities management services spanned 300 suppliers across multiple sites and product lines, each with its own locally developed service levels and pricing models. GSK sought to simplify its operating model with a stand- ardised, scalable solution with consistent, measurable service levels delivered through a few global providers. The Challenge The scale of the project added significant complexity to the lifecycle aspects of the arrangement—from strategy, due diligence, contracting and transition to operational management and global rollout. GSK selected
    [Show full text]
  • Bk Sans 005737.Pdf
    TABLE OF CONTENTS Procter & Gamble’s Earnings Per Share .3 Coca-Cola’s Earnings Per Share .3 Johnson & Johnson’s Earnings Per Share .4 United Continental’s Earnings Per Share .4 Ford Motor Company’s Earnings Per Share .5 Advance Micro Devices, Inc.’s Earnings Per Share .5 Compare Coca-Cola to Ford Motor Company .6 American Express Company .7 American Express Company Per Share Earnings History .8 The Bank of New York Mellon (BNY Mellon) .9 BNY Mellon EPS History / BNY Mellon BVPS History .10 Coca-Cola Company .11 ConocoPhillips .12 ConocoPhillips EPS History / ConocoPhillips BVPS History .13 Costco Wholesale Corporation .14 Costco EPS History / Costco BVPS History .15 GlaxoSmithKline .16 GSK’s brand-name products .17 GlaxoSmithKline’ Profile / GlaxoSmithKline’ History .18 Johnson & Johnson .19 Johnson & Johnson Per Share Book Value History .20 Kraft Foods, Inc .21 Kraft Foods EPS History / Kraft Foods BVPS History .22 Moody’s Corporation .23 Moody’s Corporation EPS History .24 Procter & Gamble Company .25 Procter & Gamble BVPS History .26 Sanofi S. A. .27 Sanofi A.S EPS ADR History / Sanofi A.S BVPS History .28 Torchmark Corporatio .29 Torchmark Corporation EPS History / Torchmark Corporation BVPS History .30 Union Pacific Corporation .31 Union Pacific Corporation NPM (Net Profit Margin) History .32 Union Pacific Corporation BVPS History / Union Pacific Corporation EPS History .32 U.S. Bancorp .33 U.S. Bankcorp EPS History / U.S. Bankcorp BVPS History .34 Wal-Mart Stores, Inc. .35 Walmart EPS History / Walmart BVPS History .36 Washington
    [Show full text]
  • Drunkorexia and Gender Role Conformity
    University of Northern Colorado Scholarship & Creative Works @ Digital UNC Dissertations Student Research 8-2020 Drunkorexia and Gender Role Conformity Sarah Zwetzig Follow this and additional works at: https://digscholarship.unco.edu/dissertations Recommended Citation Zwetzig, Sarah, "Drunkorexia and Gender Role Conformity" (2020). Dissertations. 694. https://digscholarship.unco.edu/dissertations/694 This Text is brought to you for free and open access by the Student Research at Scholarship & Creative Works @ Digital UNC. It has been accepted for inclusion in Dissertations by an authorized administrator of Scholarship & Creative Works @ Digital UNC. For more information, please contact [email protected]. © 2020 SARAH ZWETZIG ALL RIGHTS RESERVED UNIVERSITY OF NORTHERN COLORADO Greeley, Colorado The Graduate School DRUNKOREXIA AND GENDER ROLE CONFORMITY A Dissertation Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Sarah Zwetzig College of Education and Behavioral Sciences Department of Applied Psychology and Counselor Education August 2020 This Dissertation by: Sarah Zwetzig Entitled: Drunkorexia and Gender Role Conformity. has been approved as meeting the requirements for the Degree of Doctor of Philosophy in College of Education and Behavioral Sciences in Department of Applied Psychology and Counselor Education. Accepted by the Doctoral Committee: ___________________________________________________ Basilia Softas-Nall, Ph.D., Research Advisor ___________________________________________________
    [Show full text]
  • Glaxosmithkline ITA – Wikipedia
    GlaxoSmithKline - Wikipedia https://it.wikipedia.org/wiki/GlaxoSmithKline GlaxoSmithKline Da Wikipedia, l'enciclopedia libera. GlaxoSmithKline plc (Borsa di Londra: GSK (https://it.finance.yahoo.com/q?s=GSK.L), NYSE: GSK GlaxoSmithKline plc (https://www.nyse.com/quote/XNYS:GSK)) è una società britannica operante nel settore farmaceutico, biologico, e sanitario. GlaxoSmithKline è una società di ricerca con un vasto Stato Regno Unito portafoglio di prodotti farmaceutici che comprendono Forma Società per azioni antinfettivi del sistema nervoso centrale (SNC), societaria respiratorio, gastrointestinale/metabolico, oncologico e vaccini. Inoltre ha molti prodotti per l'igiene del Borse Borsa di Londra: GSK consumatore tra cui prodotti per l'igiene orale, bevande valori (https://it.finance.yahoo.com nutrizionali e medicinali da banco. È presente in 37 /q?s=GSK.L) nazioni ed in Italia possiede una sede a San Polo di NYSE: GSK Torrile, vicino a Parma. A Verona la Glaxo nasce il 30 (https://www.nyse.com marzo 1932 con il nome di Società anonima italiana /quote/XNYS:GSK) Nathan Bompiani, antesignana dell'odierna GlaxoSmithKline; dall'anno 2010 il centro ricerche di ISIN GB0009252882 Verona è condiviso con Aptuit[1]. L'Italia è stato il primo (http://www.isin.org/isin- insediamento estero dell'azienda che presto prenderà il preview nome Glaxo, dal greco "Galaktos", a simboleggiare uno /?isin=GB0009252882) dei suoi primi prodotti: il latte in polvere. Fondazione 2000 dalla fusione tra Glaxo Wellcome e SmithKline Beecham Indice Sede Londra principale
    [Show full text]
  • Annual Report 2015
    Annual Report 2015 2015 saw substantial progress to accelerate new product sales growth and strengthen our Pharmaceuticals, Vaccines and Consumer Healthcare businesses Overview of 2015 Strategic report “ In 2015, we made substantial progress to accelerate new product sales growth, integrate new businesses in Vaccines and Consumer Healthcare and restructure our global Pharmaceuticals business. This progress means the Group is well positioned to return to core earnings growth in 2016.” Sir Andrew Witty, Chief Executive Officer Governance & remunerationPerformance Financial statements summary Investor information £23.9bn £10.3bn £5.7bn £3.9bn Group turnover Total operating profit Core operating profit Cash dividends paid (up 6% CER/up 1% CER (up >100% CER) a (down 9% CER/down 3% in 2015 pro-forma) a CER pro-forma)a £2.0bn 174.3p 75.7p 10 0 % New product sales b Total earnings per share Core earnings per share Markets now operating (up >100%) (up >100%, primarily (down 15% CER, primarily new commercial model reflecting impact of reflecting short-term dilution transaction gains) of the Novartis transaction)a ~40 20 ~13 % 1st Potential new medicines Potential to file up to Estimated internal In Access to Medicine and vaccines profiled at R&D 20 assets with regulators rate of return in R&D Index event, 80% of which have by 2020 in 2015 potential to be first-in-classc Footnotes a We use a number of adjusted measures to report the performance of our business, as described on page 54. These include core results, CER growth rates and pro-forma CER growth rates. A reconciliation of total results to core results is set out on page 62.
    [Show full text]
  • Review Scottish
    INNOVATION TECHNOLOGY HEALTHCARE PHARMACY Scottish Review BIOSIMILAR MEDICINES WHAT YOU NEED TO KNOW CPD AN UPDATE WORD ON THE STREET HOMELESSNESS AND PHARMACISTS DOLLY THE SHEEP A 20-YEAR LEGACY SUMMER SPECIAL 2017 HEALTH HAZARDS IN THE SPOTLIGHT ISSUE 116 - 2017 VISIT US AT WWW.SCOTHEALTHCARE.COM 5688 QIPP advertorial in Northern Ireland Healthcare Review (NIH) v1.qxp_QIPP Zeroderma advertorial 18/01/2017 13:43 Page 1 wIdER CHoICE, GREATER SAvINGS FRom THE ZERodERmA RANGE How much could you save on emollient prescribing? The Zeroderma emollient range offers a choice of four creams, one ointment, Survey shows benefits of ® 19% Zerodouble Emollient Gel cost saving one gel and two bath additives - per pack providing complete emollient therapy Results from a recent survey with over 300 members of ® for moisturising, washing and bathing. the Psoriasis Association using Zerodouble emollient Gel showed that 97% liked the feel of Zerodouble Gel, 91% All Zeroderma products are gentle on said it was as good as or better than their current emollient the skin and do not contain the harmful and 84% wanted to continue using Zerodouble Gel. irritant sodium lauryl sulfate (SlS). Zeroderm® ointment – convenient 37% Zeroderma products are similar in formulation cost saving to around 50% of emollients currently 3-in-1 emollient therapy per pack prescribed by CCGs and offer cost savings SLS-free Zeroderm® Ointment provides a rich of up to 37%, with no compromise on 3-in-1 emollient for the management of eczema and dry skin conditions. Zeroderm Ointment can patient care. Around 75% of formularies and be used as a skin cleanser, a bath additive and as a leave-on moisturiser.
    [Show full text]
  • Biennial Review 2020
    Drug Free Schools and Campuses Regulations [EDGAR 86] Biennial Review Academic Years 2019 & 2020 The report has been compiled by: Emily Sears, MS, LCADC Zachary Hitchens, MS, LCADC, NCC Jaclyn Webber, MA December 2020 Table of Contents Executive Summary 3 Introduction to Towson University 4 Program Inventory and Assessment 5-15 Policy and Enforcement 16-18 AOD related highlights and significant accomplishments 19-20 Program strengths and areas of growth 21-25 Annual distribution protocol 26 Conclusion and recommendations 27 Appendices 28-75 2 Executive Summary This Biennial Report was compiled and written by the ATOD team, covering academic years 2018-2019 and 2019-2020. Contributions were made by campus partners to provide important information, updates, and data to support this review; contributions were made by the Office of Student Conduct & Civility Education, Human Resources, Fraternity & Sorority Life, and Housing and Residence Life to name a few. Assessment, survey, and evaluation data are important tools to help us better understand our campus community perceptions, behaviors, and needs which also serves to inform our programming goals. Consequently, this information gleaned from the CORE Survey, NCHA, and Maryland College Alcohol Survey, Party 101 evaluations, etc. also contributed largely to this report. 3 Introduction to Towson University Towson University is a public university located in Towson, Maryland, a suburb of Baltimore City. Rich in academia, the Baltimore metropolitan area boasts more than 20 colleges and universities with Towson University recognized as the largest in the immediate Baltimore area, and second-largest within the University System of Maryland. As noted on the Towson University website https://www.towson.edu/about/ataglance/, the Fall 2020 semester the total enrollment of Towson University was 21,917 students; composed of 18,730 undergraduate and 3,187 graduate students.
    [Show full text]